Join the #MAYA Project webinar on late effects of #cancer treatment in #AYA cancer survivors! PredictAYA coordinator, Kenny Rodriguez-Wallberg @ki.se joins the panel with Quality of Life (AYA) Cluster projects @transcend-xr.bsky.social #Pancare4AYA #LATE-AYA Register: us02web.zoom.us/webinar/regi...

✉️ The first PredictAYA newsletter is here! Read the newsletter to learn about the project, early achievements, collaboration with other EU initiatives, and discover latest resources: mailchi.mp/3d383c167035... ✍ Subscribe to receive the next issue: mailchi.mp/b4414d9553be... #HorzionEU #AYACancer

Last week, we brought together 13 young people from across Europe with lived experience of cancer for the 1st #PredictAYA Patient and Relatives Advisory Board (PRAB) meeting - an important step for strengthening meaningful patient engagement in the project. #AYA #Cancer #PatientEngagement #HorizonEU

Our project brochure is now available on the PredictAYA website. 📖 Take a look to learn about PredictAYA's work on understanding, predicting and preventing late effects in adolescent and young adult (#AYA) cancer survivors: predictaya.eu/wp-content/u...

The Quality of Life (AYA) Cluster meeting brought together several EU-funded projects in Brussels this week to strengthen collaboration on AYA cancer survivorship. TRANSCEND-XR was pleased to contribute to these exchanges. #CancerMission #QoLAYACluster

🎬We're closing the series "Inside PredictAYA Work Packages (WPs)" with WP9 - #Ethics WP9 ensures that all research in the project is carried out ethically and in full respect of human rights. It also reviews how artificial intelligence #AI is developed and used responsibly. Lead: @ki.se #HorizonEU

We had the pleasure to contribute to 2 important EU #CancerMission events on improving quality of life for Adolescent and Young Adult #AYA #cancersurvivors organised by @ec.europa.eu. Great to connect with collaborators like @transcend-xr.bsky.social and @youthcancereurope.bsky.social. More soon!

🎬In today's series "Inside PredictAYA Work Packages (WPs)": WP8-Data Management & Clinical Study Support WP8 organises and harmonises clinical and population-based data collected across Europe for PredictAYA. It supports the clinical studies, data collection and statistical analyses. Lead: @ki.se

Join the #EUHPP policy webinar "Cancer Mission: Quality of Life" on 2 March 2026! PredictAYA will join the panel on #qualityoflife of young cancer survivors, together with @transcend-xr.bsky.social @cancerinfoportal.bsky.social, and others. Register: ecconf.webex.com/weblink/regi... #MissionCancer

🎬Get to know PredictAYA Work Package 7-Communication, dissemination, stakeholder engagement, policy, and European initiative clustering We will engage with key stakeholder groups and other EU initiatives, and develop new #oncofertility guidelines for young cancer survivors. Lead: @nkinl.bsky.social

🎬In today's series "Inside PredictAYA Work Packages (WPs)": WP6-Postcancer reproductive health, sexuality and quality of life WP6 aims to understand how #cancer and its treatments affect #pregnancy outcomes, #sexualhealth and #qualityoflife of young survivors. Lead: @ulbruxelles.bsky.social

🌍 Today is #WorldCancerDay The theme #UnitedbyUnique reminds us that every #cancer journey is different. People-centredness is essential in #oncofertility care for adolescents and young adults (AYAs). PredictAYA contributes by delivering patient-centred solutions in oncofertility care for AYAs.

🎬In today's series "Inside PredictAYA Work Packages (WPs)": WP5-Late effect of cancer therapies on fertility and reproduction in males WP5 aims to understand how #cancer and its treatments affect #fertility in young men to support personalised #oncofertility counselling. Lead: University of Florence

🎬In today's series "Inside PredictAYA Work Packages (WPs)": WP4-Clinical research on ovarian toxicity from large cohorts across Europe WP4 aims to understand how #cancer and its treatments affect #fertility in young women to support personalised #oncofertility counselling. Lead: @unibe.ch #HorizonEU

🌟 Help shape life after testicular cancer TRANSCEND-XR is hosting World Café sessions - small, interactive online conversations where survivors and loved ones can share what life after treatment feels like. Your insights will help shape a new XR educational intervention for survivorship. 💬

🎬 In today's series "Inside PredictAYA Work Packages (WPs)": WP3 - Pharmacogenetic modelling WP3 aims to understand how cancer treatments affect fertility and long-term health in young people using innovative methods. Lead: @liu.se #HorizonEU #CancerResearch #AYAOncology #Pharmacogenetics

🎬 In today's series "Inside PredictAYA Work Packages (WPs)": WP2 - Epidemiology of late effects on European cohorts WP2 examines how cancer and its treatment affect the long-term health of adolescents and young adults (AYAs) across Europe. Lead: @ki.se i.se #HorizonEU #CancerResearch #AYA

✨ We're starting the new year with our weekly series "Inside PredictAYA Work Packages (WPs)", taking a closer look at the components and activities of the PredictAYA project. 🎬 First: WP1 - Project Management and Coordination, Data Management, IPR and Ethics Lead: @ki.se

✨ Best wishes for a happy new year from the PredictAYA team! 2025 marked the beginning of our journey, and we’re grateful to everyone who’s been part of these first steps. Wishing you a wonderful, healthy, and successful 2026!

📣 Are you a young #cancersurvivor (diagnosed aged 15-39) or a relative of someone who is? Do you want to help shape the future of care for young survivors? Join our Patient & Relatives Advisory Board! #PatientEngagement #HorizonEU #CancerResearch 👉https://predictaya.eu/call-for-interest-prab/

✨Our project website is now live! Visit us at predictaya.eu and learn about our mission and approach, project partners, synergy project, news and upcoming events. #HorizonEU #MissionCancer @ki.se @nkinl.bsky.social

🌟 Partner spotlight: Inselspital Bern. The University hospital Bern is one of Switzerland’s leading hospitals. The University Women’s hospital also focuses on research in gonadal toxicity and fertility preservation in cancer disease. In PredictAYA, Bern leads clinical research on ovarian toxicity.

🌟 Partner spotlight: Linköping University @liu.se LiU advances world-leading, translational research environments. In PredictAYA, LiU contributes to finding predictors of reproductive organ and late toxicity of cancer by working on genetic prediction models and supporting epidemiological studies.

🌟 Partner spotlight: @inserm.fr, @chuangers.bsky.social, @chulille.bsky.social, @hospicescivilslyon.bsky.social and Centre Leon Berard. The French research and oncology centres contribute to PredictAYA with collection and analysis of data from adolescent and young adult cancer survivors. #HorizonEU

🌟 Partner spotlight: Karolinska University Hospital, @regionstockholm.bsky.social Karolinska University Hospital ranks among the world's best hospitals. Its clinical program for fertility preservation is the largest in Sweden. In PredictAYA, the hospital provides clinical data and patient inclusion.

🌟 Partner spotlight: @uniheidelberg.bsky.social The Department of Gynecological Endocrinology and Fertility Disorders at the University of Heidelberg is a leading REI center in Germany. In PredictAYA, it leads communication and stakeholder engagement in Germany for patient recruitment and follow-up.

🌟 Partner spotlight: Civitta Foundation Civitta is specialised in delivering European projects across diverse sectors. In PredictAYA, the team supports project management and coordination, particularly regarding ethical guidance and data management planning. #HorizonEU

🌟 Partner spotlight: European Cancer Organisation (ECO), @europeancancer.bsky.social ECO is a not-for-profit federation of member organisations working in cancer at European level. In PredictAYA, ECO leads stakeholder engagement and policy activities. #HorizonEU

🌟 Partner spotlight: Université Libre de Bruxelles - @ulbruxelles.bsky.social The PredictAYA team at the Research Laboratory on Human Reproduction leads Work Package 6 on reproductive health, sexuality and quality of life after cancer. #HorizonEU

🌟 Partner spotlight: University of Tartu The PredictAYA team at the Institute of Clinical Medicine and the Institute of Genomics co-leads Work Package 3 with a focus on developing prediction models for late toxicity or long-term effects of cancer treatment. #HorizonEU

🌟 Partner spotlight: The University of Florence In #PredictAYA, Csilla Krausz' team at the Andrology Unit leads research activities to understand and predict late effects of cancer therapies on fertility and testicular function in male adolescent and young adult (AYA) cancer survivors. #HorizonEU

🌟 Partner spotlight: Netherlands Cancer Institute @nkinl.bsky.social. In #PredictAYA, the research group on personalised oncology in adolescents and young adults leads communication, dissemination and stakeholder engagement and supports studies on late effect of cancer treatment on European cohorts.

🌟 Partner spotlight: Ospedale Policlinico San Martino. In #PredictAYA, the team (@cmassarottimd.bsky.social) co-leads the work on gynecological follow-up after cancer therapies and provides data to analyse late effect of cancer therapies on fertility and reproductive health. #HorizonEU

🌟 Partner spotlight: Fondazione IRCCS Istituto Nazionale dei Tumori di Milano. In #PredictAYA, the oncology institute contributes to epidemiological studies of late effects of cancer treatments thanks to the EUROCARE project it leads, as well as research on #fertilitypreservation in AYAs. #HorizonEU

🌟 Partner spotlight: Medical University Innsbruck @i-med.ac.at The Department of Gynecological Endocrinology & Reproductive Medicine is a leader in #fertilitypreservation & #reproductivehealth. In #PredictAYA, it contributes to clinical data collection across project work packages. #HorizonEU

🌟 Partner spotlight: @edinburgh-uni.bsky.social‬, Centre for Reproductive Health. In #PredictAYA, the team (@rodtmitchell.bsky.social and Richard Anderson) ‬co-leads work on late effects of #cancertreatment in males and supports research on #reproductivehealth in female #cancer patients. #HorizonEU

🌟 Partner spotlight: @universityofleeds.bsky.social, School of Medicine. In #PredictAYA, the childhood and young adult research group contributes to studying the epidemiology of late effects of cancer treatment in European cohorts, pharmacogenetic modelling and statistical analysis. #HorizonEU

🌟 Partner spotlight! First up: @ki.se, Laboratory of Translational Fertility Preservation. As coordinator, the team leads key project activities, including epidemiological studies of late effects of #cancer treatment, data collection, statistical analysis, regulatory and ethics guidance. #HorizonEU

Hello Bluesky! We are #TRANSCEND-XR, a Horizon Europe project exploring how XR can support young testicular cancer survivors. Follow us for updates and insights! #HorizonEurope #DigitalHealth #EUResearch #EUCancerMission #EUResearch

🧬 Why do some #cancer patients face long-term effects from #cancertreatment, such as #infertility, while others don’t? Meet our coordinator Prof. Kenny Rodriguez-Wallberg from @ki.se and read the press release to learn how #PredictAYA will tackle this question. 🔗 news.ki.se/kenny-rodrig...

🚀 #PredictAYA has started its work! 👉Learn more about our project below and follow for updates. #MissionCancer #CancerSurvivorship #PrecisionMedicine #HorizonEU